companion pets

Shares of Nexvet Biopharma plc (NASDAQ: NVET), a nano-cap clinical-stage biopharmaceutical company that focuses on developing therapies for companion animals, surged higher by more than 15 percent early Thursday morning. Nexvet Biopharma reported results from its NV-02 pilot field study in cats...